Sorry, this entry is only available in Ukrainian.
Novo Nordisk розширює виробництво пероральних GLP-1 препаратів в Ірландії
Вас может заинтересовать:
WEB only
Investment of 350 million EUR in state-of-the-art research infrastructure is Boehringer Ingelheim’s largest single investment in Germany to date Boehringer Ingelheim strengthens innovation power and development of biopharmaceuticals, which account…
WEB only
The First Vice Prime Minister of Ukraine, the Minister of Economy of Ukraine Yulia Svyridenko visited the "Biopharma Plasma" plant as part of a working trip to the city of…
